← Browse by Condition
Medical Condition

colorectal carcinoma

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for colorectal carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — colorectal carcinoma Clinical Trials

How many clinical trials are currently recruiting for colorectal carcinoma?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for colorectal carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for colorectal carcinoma?
colorectal carcinoma research spans Phase 1 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a colorectal carcinoma clinical trial?
Eligibility criteria for colorectal carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Top Sponsors
Chinese University of Hong Kong 1 trial
National Cancer Institute (NCI) 1 trial
AstraZeneca 1 trial
Memorial Sloan Kettering Cancer Center 1 trial
Emory University 1 trial

Recruiting Clinical Trials

NCT06926374
Recruiting
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Enrollment
90 pts
Location
China
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT05630794 Phase 1
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT05877599 Phase 1
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Enrollment
45 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04489238
Recruiting
Collection of Information to Better Understand Young Onset Colorectal Cancer
Enrollment
1,366 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT05663203
Recruiting
A Web-Based Dyadic Intervention for Colorectal Cancer
Enrollment
56 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT05447923
Recruiting
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Enrollment
450 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06666192
Recruiting
The Ohio State University (OSU) SCREEN Community Program
Enrollment
2,067 pts
Location
United States
Sponsor
Ohio State University Comprehe...
View Trial →

Related Conditions

rectal prolapse (1) prostate cancer adenocarcinoma (1) bladder cancer (1) kidney cancer (1) hiatal hernia with gastroesophageal reflux disease (1) gist gastrointestinal stromal tumor (1) esophageal cancer (1) gallstones (1) gastric cancer (1) colorectal adenomatous polyp (1) familial adenomatous polyposis (1) multiple adenomatous polyps (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology